Then, as shown in Figure S6A, ABL1, BOC, FGF7, KCNK3, MAP1A, MYLK, PPARGC1A, and REEP2 were validated to be significantly higher expressed in normal tissues compared with BLCA tissues. This evidence concerns the gene MYLK and bladder transitional cell carcinoma.